CYP Enzymes & Tuberculosis (TB) Treatment
The intersection of cytochrome P450 (CYP) enzymes and TB is primarily about drug-drug interactions driven by the rifamycin class of anti-TB drugs.
Key Concept: Rifamycins as CYP Inducers
All rifamycins — rifampin (RIF), rifabutin (RFB), and rifapentine (RPT) — are broad-spectrum inducers of the CYP system. By upregulating CYP enzyme activity, they increase the metabolism of co-administered drugs, often reducing serum concentrations to subtherapeutic levels.
Potency ranking (strongest → weakest):
| Drug | CYP Induction Potency | Notes |
|---|
| Rifampin (RIF) | Strongest | Most clinically significant |
| Rifapentine (RPT) — daily | ~Equal to daily RIF | Potency depends on dosing frequency |
| Rifapentine (RPT) — once weekly | Limited | Used in LTBI regimens (e.g., 3HP with INH) |
| Rifabutin (RFB) | Weakest | Preferred in HIV co-infection |
(Treatment of Drug-Susceptible Tuberculosis, p. 24)
Clinically Important Drug Interactions via CYP Induction
Rifampin (the most potent inducer) can decrease the half-life and plasma levels of (Harrison's, p. 5271):
- Anticoagulants: Warfarin (↑ INR monitoring required)
- Antiretrovirals: Protease inhibitors, NNRTIs (major concern in HIV-TB co-infection)
- Antifungals: Azole agents (fluconazole, itraconazole, voriconazole)
- Immunosuppressants: Cyclosporine, prednisone
- Cardiovascular: Digoxin, quinidine
- CNS/neurologic: Phenytoin, methadone
- Hormonal: Oral contraceptives (risk of unintended pregnancy)
- Antibiotics: Clarithromycin
Clinical Implications
- HIV/TB co-infection: Rifabutin is often substituted for rifampin because its weaker CYP induction causes less interference with antiretroviral therapy. The CDC provides specific guidance for managing these interactions.
- Oral contraceptives: Patients should use alternative or additional contraception during rifamycin-containing TB therapy.
- Transplant patients: Cyclosporine levels can drop precipitously — therapeutic drug monitoring is essential.
- Anticoagulation: Warfarin doses often need significant upward adjustment; close INR monitoring is required.
- Once-weekly rifapentine (3HP LTBI regimen): Minimal CYP induction — a practical advantage when drug interactions are a concern.
Summary
The clinical relevance of CYP enzymes in TB is essentially the story of rifamycin-mediated CYP induction — particularly CYP3A4, CYP2C9, and others — which can render many co-administered drugs ineffective. Drug interaction review is mandatory before initiating any rifamycin-based TB regimen.